Browse Pet Safety Reports
18,010 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,010 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,010 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| May 6, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| May 6, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| May 6, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| May 5, 2024 | Horse | Horse (unknown) | Xylazine | Lack of efficacy - NOS | Outcome Unknown |
| May 5, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 3, 2024 | Horse | Horse (other), Horse (unkno... | Xylazine Hydrochloride | Excitation; Seizure NOS; Behavioural disorder NOS; Unrelated death; Lack of e... | Euthanized |
| May 3, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| May 3, 2024 | Horse | Paint | Clodronate Disodium | Alopecia local; Excessive sweating; Not himself/herself; Reluctant to move; E... | Outcome Unknown |
| May 3, 2024 | Horse | Horse (unknown) | Ponazuril | Cellulitis; Overdose | Outcome Unknown |
| May 3, 2024 | Horse | Warmblood - Dutch | Clodronate Disodium | Fever; Abnormal serum protein NOS | Outcome Unknown |
| May 2, 2024 | Horse | Horse (unknown) | Ivermectin; Praziquantel | Unclassifiable adverse event | Outcome Unknown |
| May 2, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 2, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 1, 2024 | Horse | Paint | Pergolide Mesylate | Diarrhoea; Behavioural disorder NOS | Outcome Unknown |
| May 1, 2024 | Horse | Unknown | Pergolide Mesylate | Abscess NOS; Gastric ulcer | Outcome Unknown |
| May 1, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| May 1, 2024 | Horse | Welsh Pony | Praziquantel;Moxidectin | Partial anorexia; Colic | Recovered/Normal |
| May 1, 2024 | Horse | Friesian | Omeprazole | Lack of efficacy - NOS | Ongoing |
| May 1, 2024 | Horse | Horse (other) | Ketamine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| May 1, 2024 | Horse | Horse (unknown) | Ivermectin; Praziquantel | Application site swelling; Mouth irritation | Outcome Unknown |
| May 1, 2024 | Horse | Horse (other) | Pentosan Polysulfate Sodium | Injection site swelling | Recovered/Normal |
| May 1, 2024 | Horse | Horse (unknown) | Ketamine Hydrochloride | Lack of efficacy - NOS; Unrelated death | Euthanized |
| May 1, 2024 | Horse | Unknown | Sodium Hyaluronate | Joint swelling | Outcome Unknown |
| Apr 30, 2024 | Horse | Horse (other) | Polysulfated Glycosaminoglycan | Lack of efficacy - NOS | Outcome Unknown |
| Apr 30, 2024 | Horse | Arab | Domperidone | Fever; Metritis; Leucocytosis NOS; Abnormal serum protein NOS | Outcome Unknown |
| Apr 30, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Apr 30, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Apr 30, 2024 | Horse | Thoroughbred | Pergolide Mesylate | Hives (see also Skin); Skin lesion NOS; Weight loss; Wound | Outcome Unknown |
| Apr 27, 2024 | Horse | Unknown | Sodium Hyaluronate | Swollen joint; No sign | Outcome Unknown |
| Apr 25, 2024 | Horse | Horse (unknown) | Ceftiofur Sodium | Lack of efficacy - NOS; Suspension, Abnormal | Outcome Unknown |
| Apr 24, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Apr 24, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Apr 21, 2024 | Horse | Oldenburg | Polysulfated Glycosaminoglycan | Injection site swelling; Injection site pain; Defect Unknown/Not Specified | Ongoing |
| Apr 20, 2024 | Horse | Horse (other) | Pentosan Polysulfate Sodium | Injection site swelling; Injection site pain; Muscle stiffness | Recovered/Normal |
| Apr 18, 2024 | Horse | Warmblood (unspecified) | Polysulfated Glycosaminoglycan | Vocalisation; Anaphylactic shock; Collapse NOS (see also Cardio-vascular and ... | Died |
| Apr 18, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Apr 18, 2024 | Horse | Morgan | Ceftiofur Crystalline Free Acid | Injection site pain; Injection site oedema; Pyrexia | Ongoing |
| Apr 18, 2024 | Horse | Oldenburg | Hyaluronate Sodium | Crying; Falling; Excitation; Circulatory collapse (see also Neurological and ... | Died |
| Apr 18, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Apr 18, 2024 | Horse | Horse (unknown) | Fenbendazol Oral Paste | Excessive sweating | Recovered/Normal |
| Apr 17, 2024 | Horse | Quarter Horse | Betavet | Lameness | Outcome Unknown |
| Apr 17, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site pain; Injection site skin change NOS; Injection site lump; Inj... | Recovered/Normal |
| Apr 17, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site reaction NOS; Reluctant to move; Injection site oedema | Outcome Unknown |
| Apr 16, 2024 | Horse | Appaloosa | Pentosan Polysulfate Sodium | Injection site swelling; Walking difficulty | Recovered/Normal |
| Apr 15, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Apr 13, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Apr 13, 2024 | Horse | Quarter Horse | Flunixin Meglumine Injectable | Death; Blindness; Ataxia; Falling; Necropsy performed; Septicaemia; Ulcerativ... | Died |
| Apr 13, 2024 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Injection site pain; Injection site swelling; Injection site stiffness | Ongoing |
| Apr 12, 2024 | Horse | Arab | Firocoxib | Oral ulceration | Outcome Unknown |
| Apr 12, 2024 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.